Nvidia, AMD, and Broadcom are planning big things this year. These are the biggest developments to watch in the AI chip ...

There are no shortage of stock market winners for investors to choose from looking forward to 2026. Indeed, equity returns in ...

AMD stock was up 3.52% on Friday, extending a 70.82% rally over the past 12 months. The company’s strong performance in 2025 ...

AMD stock jumped over 5% today as TD Cowen reaffirmed its Buy rating with a $290 price target and strong AI accelerator ...

Corcept sought FDA approval despite finding relacorilant was statistically no better than placebo in one of two Phase III ...

While acknowledging the potential of instability in the AI industry, TD Cowen highlighted AMD’s hardware roadmap, ...

Outlook Therapeutics' stock fell to a new low due to FDA rejection of its Lytenava filing for wet AMD. Efficacy evidence ...

The stock is valued at the low end of where the big tech companies normally trade. Taiwan Semiconductor Manufacturing (NYSE: ...

Alpha Wealth Funds, LLC, an investment management company, released its Q3 2025 letter for the “Insiders Fund”. A copy of the ...

Major stock indexes ended lower for a fourth straight session on the final trading day of 2025, although they posted ...

AMD stock sees 32 unusual options trades as calls dominate, whales target $140–$280, and investors eye earnings in 34 days.

Investing.com -- Outlook Therapeutics (NASDAQ:OTLK) stock plummeted 67.7% in after-hours trading Wednesday after the company announced that U.S. regulators rejected its application for a bevacizumab ...